Notify me when NORTHSTRIVE FUND II LP files a new Schedule 13D/G report.
⭐ Subscribe ⭐| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| NVNO | enVVeno Medical Corp | Common Stock, par value $0.00001 per share | 5% | $331,842 | 33,151 | 0% | Braeden Lichti | 20 Feb 2026 | |
| Bluejay Diagnostics, Inc. | Common Stock, $0.0001 par value per share | 5% | 35,500 | Braeden Lichti | 05 Feb 2026 | ||||
| ENVB | ENVERIC BIOSCIENCES, INC. | Common Stock, $0.01 par value per share | 0% | $0 | -$163,363 | 0 | -100% | Northstrive Fund II LP | 09 Dec 2025 |
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|